Tissue Engineering has been defined as "an interdisciplinary field that applies the principles of engineering and life sciences toward the development of biological substitutes that restore, maintain, or improve tissue function or a whole organ" 1 . Tissue engineering uses a combination of biological, mechanical and biomaterials principles to improve or replace biological functions. It is most relevant in situations where healing and tissue repair after injury or disease is sub-optimal, and in such situations tissue engineering is intended to produce a more biologically relevant repair which will result in decreased morbidity and enhanced function. Tissue engineering overlaps closely with the field of regenerative medicine and stem cell biology as often techniques from these two disciplines are required to successfully differentiate cells to a relevant phenotype necessary to engineer a biologically relevant construct. There is a huge unmet clinical need to improve treatment for tendon and ligament injuries in the horse. Whilst such injuries are most common in animals used for fast galloping disciplines, tendon and ligament injuries are observed in all types of horses. It has been estimated that the incidence of tendon injuries in populations of racehorses is in the region of 8-43%
2 and 46% of all injuries that occur on UK racecourses are ligament or tendon injuries 3,4 . Whilst there have been many approaches proposed for treatment of tendon and ligament injuries in the horse, so far no treatment has been identified to cause an improvement in prognosis over purely conservative approaches such as rest and controlled exercise alone 2 . Tendons do heal well but the scar tissue that is formed as a result of the repair process is both biologically and biomechanically deficient in comparison to normal tendon: This has important consequences for the animal both in terms of their future athletic performance and the substantial risk of re-injury 5 . There is good evidence that tendon heals by production of a fibrochondrogenic scar tissue which is functionally inferior to normal tissue 6 . Tissue engineering has the potential in the future to improve the biological repair of tendons resulting in improved function and decreased injury rates in animals after tendon injury. Whilst tendon tissue engineering is a very attractive clinical proposition there are many hurdles which have to be overcome before it becomes a validated clinical reality. Compared to many tissues, tendon has many challenges which will slow up progress in developing tissue engineering applications. One of the major problems is that the developmental biology of tendon is poorly understood. To fully develop and exploit regenerative therapies, it is usually necessary to have a fully understanding of the signalling and cellular events which occur during tissue development, as regenerative therapies usually try and mimic this process. For many mesenchymal tissues, such as bone and cartilage, the developmental biology of such tissues is fully resolved in species such as man and mice; hence it is much simply to come up with tissue engineering solutions which replicate this developmental process. In contrast, the molecular events which occur during tendon and ligament development are far from clear, hence it is more difficult to engineer a reparative approach with our current levels of knowledge [7] [8] [9] . Tendon tissue engineering is also hampered due to a lack of good in-vivo and in-vitro models which can be used to study tendon cell differentiation and techniques relevant to tendon repair. Whilst the horse is probably the best model it is both expensive and has ethical issues. Furthermore, no tendon injury model in the horse has so far been demonstrated to recreate the natural disease. Finally tendon tissue engineering in the veterinary species is being hampered by the lack of research effort in human medicine. Whilst tendon injuries are common in man, they are not perceived by research funders to cause levels of morbidity which are comparable to target diseases such as osteoarthritis. Hence there is much greater research investment into tissue engineering of structures such as cartilage. Thus tendon tissue engineering is an under-researched and under-developed discipline. Tissue engineering relies on the interaction of three distinct disciplines. Firstly, it requires a cell population which can be manipulated to differentiate to a relevant repair tissue. Secondly, tissue engineering requires some form of either biological or synthetic biomaterial scaffold on which cells can be grown to produce a tissue engineered construct. Finally, there is a requirement for signals to act on the cells to force relevant differentiation. By utilisation of these three items, the aim of tissue engineering is to produce neotendon which is going to be superior to that that occurs from natural repair alone.
CELLS AND TENDON TISSUE ENGINEERING
The use of mesenchymal cells transplanted to the site of a tendon injury is relatively commonly done and is an attractive proposition for effecting regeneration of equine tendon. Reports of cell treatments for tendon and ligament disease are now numerous although so far there have been no published studies identifying benefit for any claimed cell treatment in the horse 5, [10] [11] [12] [13] . This is more due to studies lacking suitable controls or being experimental studies with short term time points than a definite failure of proof of this technology. Currently there are a number of studies underway in both Europe and North America using either naturally occurring disease or experimental models of tendon disease to identify effects of cell treatment in this disease in the horse, although data collection from these studies and its analysis is not likely to be complete for several years. Key questions still need to be resolved concerning the application of cellular treatments. These include: The challenges in scaffold design are to match polymer degradation with extracellular matrix (ECM) formation and to produce scaffolds that maintain sufficient mechanical strength during the early healing phase, which then allows newly formed tissue to take up the biomechanical load. The scaffold constructs so far have rarely mimicked the morphology of the natural tissue at the ultrastructural level and it is likely that this will be to be very important in structural tissues that have directional orientation and hierarchical structures such as tendons. We are developing electrospinning techniques to produce fibres of controllable diameter and orientation [14] which can be used in tendon tissue engineering and allow a longitudinal orientation of tendon cells. Current tissue engineering approaches for tendon repair in the horse do not rely on the use of any scaffold and it remains to be seen how such techniques could be implemented in clinical practice and whether they hold any advantage over current techniques.
SIGNALS TO EFFECT CELL DIFFERENTIATION
In tissue engineering it is important that relevant signals are given to cells to effect tenogenesis; however, what signals required to effect relevant cell differentiation are poorly understood although there is a growing understanding of this field 15 . In the horse intralesional IGF-1 therapy has been performed for many years 16 , and more recently the use of both platelet rich plasma and bone marrow supernatant has been growing in popularity [17] [18] [19] . The use of tensional loading has been recognised as an important stimuli for tenogenesis 20, 21 . The most relevant signals required to facilitate tendon repair requires defining. Advances in tissue engineering of tendon are an important clinical need. Whilst such techniques are already being used clinically it is likely that our current approaches will be perceived as crude and primitive in the future.
